These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25488375)

  • 1. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.
    Carenco C; Faure S; Herrero A; Assenat E; Duny Y; Danan G; Bismuth M; Chanques G; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
    Liver Int; 2015 Jun; 35(6):1748-55. PubMed ID: 25488375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management.
    Carenco C; Faure S; Ursic-Bedoya J; Herrero A; Pageaux GP
    World J Gastroenterol; 2016 Jan; 22(1):427-34. PubMed ID: 26755888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of lymphoproliferative disease after liver transplantation.
    Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
    Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
    Perbos E; Juinier E; Guidicelli G; Dromer C; Merville P; Billes MA; Taupin JL; Neau-Cransac M
    Clin Transplant; 2014 Sep; 28(9):1054-60. PubMed ID: 25040585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant.
    Kahvecioglu S; Ersoy A; Gullulu M; Dirican M
    Exp Clin Transplant; 2014 Aug; 12(4):334-42. PubMed ID: 24447269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.
    Neuberger J; Gunson B; Hubscher S; Nightingale P
    Liver Transpl; 2004 Apr; 10(4):488-91. PubMed ID: 15048790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-lymphoid cancer after liver transplantation.
    Frezza EE; Fung JJ; van Thiel DH
    Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
    Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
    J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
    Rademacher S; Seehofer D; Eurich D; Schoening W; Neuhaus R; Oellinger R; Denecke T; Pascher A; Schott E; Sinn M; Neuhaus P; Pratschke J
    Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents.
    Brito-Costa A; Pereira-da-Silva L; Papoila AL; Alves M; Mateus É; Nolasco F; Barroso E
    Transplantation; 2016 Aug; 100(8):1714-22. PubMed ID: 27136260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
    Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship.
    Carenco C; Assenat E; Faure S; Duny Y; Danan G; Bismuth M; Herrero A; Jung B; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
    Am J Transplant; 2015 Mar; 15(3):678-86. PubMed ID: 25648361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in de novo food allergies after pediatric liver transplantation: tacrolimus vs. cyclosporine immunosuppression.
    Lebel MJ; Chapdelaine H; Paradis L; Des Roches A; Alvarez F
    Pediatr Transplant; 2014 Nov; 18(7):733-9. PubMed ID: 25156571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.